| scholarly article | Q13442814 |
| P50 | author | Erle S Robertson | Q88590600 |
| P2093 | author name string | Jie Lu | |
| Qiliang Cai | |||
| Shuvomoy Banerjee | |||
| Andrew D Hislop | |||
| Richard Dzeng | |||
| Amanda Cervini | |||
| P2860 | cites work | Regulation of major histocompatibility complex class II genes | Q24289448 |
| Interferon regulatory factor 4 is involved in Epstein-Barr virus-mediated transformation of human B lymphocytes | Q24646670 | ||
| Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma | Q28242984 | ||
| Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas | Q28299069 | ||
| MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers | Q28306431 | ||
| Negative regulation of Toll-like-receptor signaling by IRF-4. | Q28587563 | ||
| Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease | Q29619158 | ||
| EC5S ubiquitin complex is recruited by KSHV latent antigen LANA for degradation of the VHL and p53 tumor suppressors | Q33261811 | ||
| IRF4 silencing inhibits Hodgkin lymphoma cell proliferation, survival and CCL5 secretion | Q82651321 | ||
| Interferon Regulatory Factor 4: Combinational Control of Lymphocyte Differentiation | Q84791007 | ||
| Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 3 inhibits gamma interferon and major histocompatibility complex class II expression | Q42059350 | ||
| Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes. | Q42123661 | ||
| Identification of distinct regions of 5' flanking DNA that mediate constitutive, IFN-gamma, STAT1, and TGF-beta-regulated expression of the class II transactivator gene. | Q42453992 | ||
| Kaposi sarcoma herpesvirus-encoded vFLIP and vIRF1 regulate antigen presentation in lymphatic endothelial cells. | Q42502875 | ||
| IRF-1 deficiency skews the differentiation of dendritic cells toward plasmacytoid and tolerogenic features. | Q43871949 | ||
| Differential regulation of class II MHC determinants on macrophages by IFN-gamma and IL-4. | Q44938035 | ||
| IRF-4 expression in the human myeloid lineage: up-regulation during dendritic cell differentiation and inhibition by 1alpha,25-dihydroxyvitamin D3. | Q46437047 | ||
| E47, IRF-4, and PU.1 synergize to induce B-cell-specific activation of the class II transactivator promoter III (CIITA-PIII). | Q47225499 | ||
| MHC class II-specific T cells can develop in the CD8 lineage when CD4 is absent. | Q51115513 | ||
| Kaposi's sarcoma-associated herpesvirus LANA hitches a ride on the chromosome. | Q53621344 | ||
| T-cell immunity to Kaposi sarcoma-associated herpesvirus: recognition of primary effusion lymphoma by LANA-specific CD4+ T cells | Q57259563 | ||
| Regulation of Fc receptor for IgE (CD23) and class II MHC antigen expression on Burkitt's lymphoma cell lines by human IL-4 and IFN-gamma | Q70051187 | ||
| Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function | Q71984887 | ||
| The latency-associated nuclear antigen tethers the Kaposi's sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells | Q73184792 | ||
| Activation of the MHC class II transactivator CIITA by interferon-gamma requires cooperative interaction between Stat1 and USF-1 | Q74277987 | ||
| Protein complexes associated with the Kaposi's sarcoma-associated herpesvirus-encoded LANA. | Q33282107 | ||
| p53 inhibition by the LANA protein of KSHV protects against cell death | Q33885642 | ||
| Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA. | Q33886675 | ||
| HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma | Q33889296 | ||
| Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) binds ATF4/CREB2 and inhibits its transcriptional activation activity | Q33922095 | ||
| Two distinct gamma interferon-inducible promoters of the major histocompatibility complex class II transactivator gene are differentially regulated by STAT1, interferon regulatory factor 1, and transforming growth factor beta | Q33957154 | ||
| Epstein-Barr virus nuclear antigen 3C stabilizes Gemin3 to block p53-mediated apoptosis | Q34102722 | ||
| The RBP-Jκ binding sites within the RTA promoter regulate KSHV latent infection and cell proliferation | Q34130213 | ||
| Kaposi's sarcoma herpesvirus upregulates Aurora A expression to promote p53 phosphorylation and ubiquitylation | Q34186981 | ||
| Chromosome binding site of latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus is essential for persistent episome maintenance and is functionally replaced by histone H1 | Q34350776 | ||
| Expression of the MHC class II transactivator (CIITA) type IV promoter in B lymphocytes and regulation by IFN-gamma | Q34696238 | ||
| The single RBP-Jkappa site within the LANA promoter is crucial for establishing Kaposi's sarcoma-associated herpesvirus latency during primary infection | Q35077558 | ||
| Molecular Biology of Kaposi's Sarcoma-associated Herpesvirus and Related Oncogenesis | Q35124404 | ||
| Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma | Q35131811 | ||
| The internal Kaposi's sarcoma-associated herpesvirus LANA regions exert a critical role on episome persistence | Q35140238 | ||
| Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis | Q35175590 | ||
| Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. | Q35809792 | ||
| MHC class II transactivator (CIITA) expression is upregulated in multiple myeloma cells by IFN-gamma | Q35842817 | ||
| Kaposi's sarcoma-associated herpesvirus inhibits expression and function of endothelial cell major histocompatibility complex class II via suppressor of cytokine signaling 3 | Q36155542 | ||
| The pIV-otal class II transactivator promoter regulates major histocompatibility complex class II expression in the thymus | Q36369511 | ||
| Selective abrogation of major histocompatibility complex class II expression on extrahematopoietic cells in mice lacking promoter IV of the class II transactivator gene. | Q36369564 | ||
| Both IFN-gamma and IL-4 induce MHC class II expression at the surface of mouse pro-B cells | Q36511198 | ||
| IRF4 addiction in multiple myeloma | Q36891060 | ||
| IRF-4 functions as a tumor suppressor in early B-cell development | Q36948612 | ||
| The Kaposi's Sarcoma-associated Herpesvirus-encoded vIRF-3 Inhibits Cellular IRF-5 | Q37136785 | ||
| Repression of IRF-4 target genes in human T cell leukemia virus-1 infection | Q38362324 | ||
| The central repeat domain 1 of Kaposi's sarcoma-associated herpesvirus (KSHV) latency associated-nuclear antigen 1 (LANA1) prevents cis MHC class I peptide presentation | Q39591598 | ||
| Characterization of a novel human herpesvirus 8-encoded protein, vIRF-3, that shows homology to viral and cellular interferon regulatory factors | Q39593162 | ||
| Kaposi's sarcoma-associated herpesvirus inhibits interleukin-4-mediated STAT6 phosphorylation to regulate apoptosis and maintain latency | Q39665994 | ||
| Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus (KSHV) upregulates survivin expression in KSHV-Associated B-lymphoma cells and contributes to their proliferation | Q39852047 | ||
| In cis inhibition of antigen processing by the latency-associated nuclear antigen I of Kaposi sarcoma herpes virus | Q40257446 | ||
| Expression of Kaposi's sarcoma-associated herpesvirus-encoded K10/10.1 protein in tissues and its interaction with poly(A)-binding protein | Q40276880 | ||
| CD4+ T-cell responses to Epstein-Barr virus (EBV) latent-cycle antigens and the recognition of EBV-transformed lymphoblastoid cell lines | Q40441967 | ||
| Kaposi's sarcoma-associated herpesvirus-encoded viral IRF3 modulates major histocompatibility complex class II (MHC-II) antigen presentation through MHC-II transactivator-dependent and -independent mechanisms: implications for oncogenesis | Q40529241 | ||
| Disruption of the B-cell specific transcriptional program in HHV-8 associated primary effusion lymphoma cell lines | Q40669895 | ||
| Quantitative control of MHC class II expression by the transactivator CIITA. | Q41055792 | ||
| Dissection of the interferon gamma-MHC class II signal transduction pathway reveals that type I and type II interferon systems share common signalling component(s) | Q41520809 | ||
| Kaposi's sarcoma-associated herpesvirus latent protein LANA interacts with HIF-1 alpha to upregulate RTA expression during hypoxia: Latency control under low oxygen conditions | Q42049779 | ||
| Cytomegalovirus inhibits major histocompatibility class II expression on infected endothelial cells | Q42050049 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 10 | |
| P304 | page(s) | e1003751 | |
| P577 | publication date | 2013-10-31 | |
| P1433 | published in | PLOS Pathogens | Q283209 |
| P1476 | title | IRF-4-mediated CIITA transcription is blocked by KSHV encoded LANA to inhibit MHC II presentation | |
| P478 | volume | 9 |
| Q36646579 | Cytoplasmic isoforms of Kaposi sarcoma herpesvirus LANA recruit and antagonize the innate immune DNA sensor cGAS |
| Q64969424 | Direct Inhibition of IRF-Dependent Transcriptional Regulatory Mechanisms Associated With Disease. |
| Q45323918 | Ebola virus secreted glycoprotein decreases the anti-viral immunity of macrophages in early inflammatory responses |
| Q38817881 | Giving CD4+ T cells the slip: viral interference with MHC class II-restricted antigen processing and presentation. |
| Q64250362 | Impact of HVT Vaccination on Splenic miRNA Expression in Marek's Disease Virus Infections |
| Q49248446 | Impaired IFN-α-mediated signal in dendritic cells differentiates active from latent tuberculosis |
| Q64898709 | Interferon Regulatory Factors 1 and 2 Play Different Roles in MHC II Expression Mediated by CIITA in Grass Carp, Ctenopharyngodon idella. |
| Q89965497 | KSHV: Immune Modulation and Immunotherapy |
| Q38903379 | Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Inhibits Major Histocompatibility Complex Class II Expression by Disrupting Enhanceosome Assembly through Binding with the Regulatory Factor X Complex |
| Q34059252 | Kaposi's sarcoma-associated herpesvirus K3 and K5 ubiquitin E3 ligases have stage-specific immune evasion roles during lytic replication |
| Q38760916 | Major Histocompatibility Complex Class II HLA-DRα Is Downregulated by Kaposi's Sarcoma-Associated Herpesvirus-Encoded Lytic Transactivator RTA and MARCH8. |
| Q40876736 | Repression of CIITA by the Epstein-Barr virus transcription factor Zta is independent of its dimerization and DNA binding |
| Q47570715 | TLRs/NLRs: Shaping the landscape of host immunity. |
| Q26747452 | The Modulation of Apoptotic Pathways by Gammaherpesviruses |
| Q26767186 | The Role of Gammaherpesviruses in Cancer Pathogenesis |
Search more.